Yuyu Pharma (000220) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma (000220) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Yuyu Pharma - Total Liabilities Trend (2011–2024)

This chart illustrates how Yuyu Pharma's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Yuyu Pharma's working capital to evaluate short-term liquidity relative to the company's equity base.

Yuyu Pharma Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Pembangunan Jaya Ancol Tbk JK:PJAA	Indonesia	Rp1.70 Trillion
Scan-D TWO:6195	Taiwan	NT$2.33 Billion
SINCLAIRS HOTELS ORD (BSE) NSE:SINCLAIR	India	Rs486.55 Million
Enwell Energy plc F:RHN	Germany	€18.84 Million
EPE Capital Partners Ltd JSE:EPE	South Africa	ZAC29.24 Million
Ctac N.V AS:CTAC	Netherlands	€40.79 Million
Hsinjing Holding Co Ltd TWO:3713	Taiwan	NT$2.08 Billion
Heritage Global Inc NASDAQ:HGBL	USA	$17.22 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Yuyu Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuyu Pharma stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma (2011–2024)

The table below shows the annual total liabilities of Yuyu Pharma from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	+24.69%
2013-12-31	₩23.99 Billion ≈ $16.26 Million	+25.08%
2012-12-31	₩19.18 Billion ≈ $13.00 Million	-9.87%
2011-12-31	₩21.28 Billion ≈ $14.42 Million	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.48 Million

₩64.16 Billion KRW

Market Cap Rank

#22479 Global

#1426 in Korea

Share Price

₩3965.00

Change (1 day)

-2.70%

52-Week Range

₩3640.00 - ₩4770.00

All Time High

₩16106.03